Navigation Links
Patient Doing Well Weeks After Historic 4-level AxioMed Viscoelastic Disc Replacement
Date:2/16/2017

AxioMed announced today the success of the first viscoelastic 4-level cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial Hospital in Kingston, Jamaica. The procedure was performed on a 55-year-old practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative cervical discs at levels C3-7. The patient failed conservative treatments prior to undergoing surgery.

Dr. Chin believes that viscoelastic disc technology will broaden the indication of cervical and lumbar treatment to include patients with abnormal alignment and motion, and will also treat patients that would classically qualify for fusion. Dr. Chin also believes that the design can be customized to treat scoliosis without fusion.

The AxioMed viscoelastic disc is a next-generation disc replacement that restores natural disc alignment and motion. The AxioMed disc is the most advanced in comparison to other disc replacement devices because its simple design and polymer core restores all natural disc characteristics such as height, lordosis, stability, and motion in the human spine. To view a side by side of disc motion vs. natural spine motion, visit https://www.youtube.com/watch?v=tq-lK5-p3sQ.

Dr. Chin, a former Bohlman fellow, said, “I can only imagine the pride Dr. Bohlman would feel with this type of innovation; he was always a proponent of anterior solutions to cervical spine disease.” Dr. Chin continued, “The AxioMed cervical disc is extremely easy to implant and has a great anatomical fit for restoring natural motion in the cervical spine.”

Jake Lubinski, president of AxioMed, was present during the procedure and added, “The simplicity and reliability of the AxioMed disc technology makes it ideal for surgeons of any level of training or technical proficiency to use the disc. Dr. Chin used very little fluoroscopy to get ideal placement, because you can actually see around the inserter and implant as it’s being implanted.”

Dr. Chin was born in Jamaica and has been doing surgery there for the last ten years. He expressed good fortune to be able to offer this technology to Jamaicans. “There is no need for expensive equipment, so doing this procedure in developing countries isn’t difficult; you can expect superior results over fusion or first generation disc replacement.” Dr. Chin believes this makes the AxioMed disc the ideal candidate for expanding medical tourism in countries like Jamaica, which is geographically advantageous for patients looking for AxioMed access while waiting for USA FDA clearance.

About AxioMed
Founded in 2001, AxioMed began its journey of exhaustively proving the Freedom® Disc through clinical studies in the USA and Europe, research, development, and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14071809.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. BERG Initiates Phase I/II Monotherapy Trial of BPM 31510-IV in Patients with Glioblastoma Multiforme (GBM)
2. Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase 2 Data Demonstrating 11-Month Duration-of-Action After a Single Dose in Patients With Glaucoma
3. The Conference Forum Announces 4th Annual “Patients as Partners” US Event
4. MedAvante Names Leader for Patient-Focused eSolutions
5. Asterias Announces Additional Motor Function Improvement at 6-months and 9-months Following Treatment with AST-OPC1 in Patients with Complete Cervical Spinal Cord Injuries
6. Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
7. Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI
8. Harris Poll: Only Nine Percent of U.S. Consumers Believe Pharma and Biotechnology Put Patients over Profits; Only 16 Percent Believe Health Insurers Do
9. Malaria Drug Successfully Treats 26-year-old Brain Cancer Patient
10. Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease
11. Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Looking for ... and cooking events company, offers one-of-a-kind gifts, ranging from gourmet cooking experiences to ... cuisine, and guests leave inspired with new cooking tips and techniques, thanks to ...
(Date:4/26/2017)... ... 2017 , ... NextSteps 2017, NetDimensions’ annual global user conference, ... May on the following dates: , ?    London, UK from May 10-11, ?    New Orleans, ... Performance Institute will be the opening keynote speaker at the NextSteps EMEA ...
(Date:4/25/2017)... ... April 25, 2017 , ... L3 Clinical Trials, the Clinical ... is now a certified iMedNet eClinical and Electronic Data Capture software designer for ... research team to build, customize and manage clinical trial data capture and databases ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... denaturation in a cellular milieu; however, the broad application of this cellular target ... platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods for ...
Breaking Biology Technology:
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
Breaking Biology News(10 mins):